Literature DB >> 18343081

Melatonin inhibitory effect on cAMP accumulation in the chick retina development.

Lucia de Fatima Sobral Sampaio1.   

Abstract

During vertebrate neurodevelopment, neuritogenesis and synaptogenesis are modulated by intracellular cAMP rises. Melatonin, which is implicated in neuronal differentiation, mainly inhibits this pathway. Here, an investigation about the profile of this effect during the vertebrate neurodevelopment is reported. In the embryonic chick retinas at days 8, 12, 14, 16 and at 2 days post-hatched (E8, E12, E14, E16 and PH), those control embryonic retinas incubated only with the phosphodiesterase inhibitor at days corresponding to commencement of neuronal differentiation (E8, E12) and PH, presented cAMP levels inhibited by melatonin. While the cAMP accumulation stimulated by forskolin was inhibited in the embryonic retinas at all testing days. Neither the unselective antagonist N-acetyl-2-benziltryptamine (luzindole) nor the selective Mel(1b) antagonist 4-phenyl-2-propionamidotetralin (4-P-PDOT) blocked the melatonin concentration-dependent inhibitory effect on cAMP accumulation in the retinas initiating differentiation (E7-E9), suggesting a tight binding between melatonin and their receptors. However, 4-P-PDOT competitively reverted the melatonin effect on cAMP stimulated by forskolin during synaptogenesis stages. Together, the melatonin effect on cAMP levels in chick retina, which is mainly through melatonin receptors, is depending on the developmental period observed, probably taking part in the mechanisms surrounding the melatonin action on neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343081     DOI: 10.1016/j.ijdevneu.2008.02.001

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  2 in total

1.  Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.

Authors:  Nan Wu; Guido Carpino; Ludovica Ceci; Leonardo Baiocchi; Heather Francis; Lindsey Kennedy; Tianhao Zhou; Lixian Chen; Keisaku Sato; Konstantina Kyritsi; Vik Meadows; Burcin Ekser; Antonio Franchitto; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2021-11-24       Impact factor: 17.425

2.  MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro.

Authors:  Rafael V Sampaio; Stefanne Dhúllia B Conceição; Moysés S Miranda; Lucia de Fatima S Sampaio; Otávio Mitio Ohashi
Journal:  Reprod Biol Endocrinol       Date:  2012-12-03       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.